Research Article

The Usefulness of Genotyping of Celiac Disease-Specific HLA among Children with Type 1 Diabetes in Various Clinical Situations

Table 1

Characteristic of the studied groups and the results of the genetic tests.

Group I: 92 (63%)Group II: 30 (21%)Group III: 23 (16%)Groups II and III: 53 (37%) value group I (T1D) vs. groups II and III (CD) value group II vs. group III value (all groups)

Female ( (%))32 (35%)16 (53%)8 (35%)24 (45%)NSNSNS
( (%))56 (61%)21 (70%)15 (65%)36 (68%)NSNSNS
( (%))65 (71%)24 (80%)16 (70%)40 (75%)NSNSNS
(n (%))15 (16%)4 (13%)3 (13%)7 (13%)NSNSNS
( (%))53 (58%)18 (60%)17 (74%)35 (66%)NSNSNS
( (%))52 (57%)4 (13%)9 (39%)13 (25%)0.0010.0310.001
Age at T1D diagnosis (years) (Me (IQR))9.99 (5.32–13.52)5.19 (2.38–9.10)5.60 (3.16–7.88)5.41 (2.84–8.71)0.001NS0.001
Age at CD diagnosis (years) (Me (IQR))7.30 (5.10–11.10)6.96 (4.80–11.53)7.23 (5.04–11.32)NSNS
TTG (U/ml)4.8 (3.3–7.6)160.0 (71.9–704.0)73.6 (51.0–118.0)109.6 (60.0–321.0)0.0010.0040.001
ZnT8 (U/ml)221.0 (29.8–539.9)110.0 (4.9–529.0)166.3 (15.3–310.7)120.0 (5.1–507.4)NSNSNS
IA2 (U/ml)216.0 (3.9–722.0)21.7 (7.0–922.0)185.9 (1.6–666.1)96.6 (3.8–801.1)NSNSNS
GAD (U/ml)83.0 (6.7–560.0)51.9 (5–375.0)42.7 (13.3–402.6)49.0 (8.6–395.2)NSNSNS